These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3577210)
1. Dietary method for reducing fluctuations in Parkinson's disease. Pincus JH; Barry KM Yale J Biol Med; 1987; 60(2):133-7. PubMed ID: 3577210 [TBL] [Abstract][Full Text] [Related]
2. [Influence of protein-restricted diet on motor response fluctuations in Parkinson's disease]. Hirata H; Asanuma M; Kondo Y; Ogawa N Rinsho Shinkeigaku; 1992 Sep; 32(9):973-8. PubMed ID: 1300270 [TBL] [Abstract][Full Text] [Related]
3. [Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease]. Sanchís G; Mena MA; Martín del Río R; Morales B; Casarejo MJ; de Yébenes MJ; Tabernero C; Jiménez A; de Yébenes JG Arch Neurobiol (Madr); 1991; 54(6):296-302. PubMed ID: 1811460 [TBL] [Abstract][Full Text] [Related]
4. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease. Nutt JG; Carter JH; Lea ES; Woodward WR Mov Disord; 1997 May; 12(3):285-92. PubMed ID: 9159720 [TBL] [Abstract][Full Text] [Related]
5. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. Nutt JG; Woodward WR; Hammerstad JP; Carter JH; Anderson JL N Engl J Med; 1984 Feb; 310(8):483-8. PubMed ID: 6694694 [TBL] [Abstract][Full Text] [Related]
6. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients]. García de Yébenes J; Mateo D; Pino MA; Cordero M; Pastor M; Chacón J; Morales B; Sánchez V; Mena MA; Giménez Roldán S Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023 [TBL] [Abstract][Full Text] [Related]
7. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
8. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease. Simon N; Gantcheva R; Bruguerolle B; Viallet F Parkinsonism Relat Disord; 2004 Mar; 10(3):137-42. PubMed ID: 15036167 [TBL] [Abstract][Full Text] [Related]
10. Role of an electronic armband in motor function monitoring in patients with Parkinson's disease. Cereda E; Pezzoli G; Barichella M Nutrition; 2010 Feb; 26(2):240-2. PubMed ID: 19804956 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study]. Chaná P; Fierro A; Reyes-Parada M; Sáez-Briones P Rev Med Chil; 2003 Jun; 131(6):623-31. PubMed ID: 12942590 [TBL] [Abstract][Full Text] [Related]
12. [Proposal for a protein redistribution diet in the control of motor fluctuations in Parkinson's disease: acceptance and efficacy]. Giménez-Roldán S; Mateo D; García Almansa A; García Peris P Neurologia; 1991 Jan; 6(1):3-9. PubMed ID: 1863456 [TBL] [Abstract][Full Text] [Related]
13. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH; Klasser M; Reichmann H Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [TBL] [Abstract][Full Text] [Related]